- Home
- IBIO vs PASW Comparison
IBIO vs PASW Comparison
Compare IBIO & PASW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- PASW
- Stock Information
- Founded
- IBIO 2008
- PASW 2021
- Country
- IBIO United States
- PASW Hong Kong
- Employees
- IBIO N/A
- PASW N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- PASW Apparel
- Sector
- IBIO Health Care
- PASW Consumer Discretionary
- Exchange
- IBIO Nasdaq
- PASW Nasdaq
- Market Cap
- IBIO 16.4M
- PASW 15.9M
- IPO Year
- IBIO N/A
- PASW N/A
- Fundamental
- Price
- IBIO $1.18
- PASW $0.46
- Analyst Decision
- IBIO Strong Buy
- PASW
- Analyst Count
- IBIO 4
- PASW 0
- Target Price
- IBIO $4.50
- PASW N/A
- AVG Volume (30 Days)
- IBIO 2.2M
- PASW 399.2K
- Earning Date
- IBIO 11-12-2025
- PASW 01-12-2026
- Dividend Yield
- IBIO N/A
- PASW N/A
- EPS Growth
- IBIO N/A
- PASW N/A
- EPS
- IBIO N/A
- PASW N/A
- Revenue
- IBIO $500,000.00
- PASW $8,286,193.00
- Revenue This Year
- IBIO N/A
- PASW N/A
- Revenue Next Year
- IBIO $33.34
- PASW N/A
- P/E Ratio
- IBIO N/A
- PASW N/A
- Revenue Growth
- IBIO 185.71
- PASW N/A
- 52 Week Low
- IBIO $0.56
- PASW $0.34
- 52 Week High
- IBIO $6.89
- PASW $5.40
- Technical
- Relative Strength Index (RSI)
- IBIO 50.97
- PASW N/A
- Support Level
- IBIO $0.96
- PASW N/A
- Resistance Level
- IBIO $1.28
- PASW N/A
- Average True Range (ATR)
- IBIO 0.12
- PASW 0.00
- MACD
- IBIO -0.03
- PASW 0.00
- Stochastic Oscillator
- IBIO 54.68
- PASW 0.00
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About PASW Ping An Biomedical Co. Ltd. Ordinary Shares
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.